Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 2.156 5-jähriger Impact-Faktor: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.2013006641
pages 93-101

ANP-NPRA Signaling Pathway−A Potential Therapeutic Target for the Treatment of Malignancy

Zhilong Zhao
Department of Surgical Oncology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China
Jia Zhang
Department of Thoracic Surgery, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China
Min Li
Department of Surgical Oncology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China
Ya Yang
Department of Surgical Oncology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China
Kai Sun
Department of Surgical Oncology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China
Jiansheng Wang
Tianjin University

ABSTRAKT

It was well established that the atrial natriuretic peptide (ANP)/natriuretic peptide receptor-A (NPRA) signaling pathway controls natriuretic, diuretic, vasorelaxant, and anti-proliferative responses in the regulation of the human cardiovascular system by previous studies. Yet in recent years, more and more evidence has shown that the ANP/NPRA signaling pathway plays an important role in human cancer. For example, NPRA is abundantly expressed on tumorigenic mouse and human prostate cancer (PCa) cells, but not in nontumorigenic prostate epithelial cells and down-regulation of NPRA-induced apoptosis in PCa cells. Dexamethasone can increase the expression of ANP markedly, and that is the reason why dexamethasone is the cornerstone in the treatment of multiple myeloma. NPRA deficiency can substantially protect C57BL/6 mice from lung, skin, and ovarian cancers. These results strongly suggest ANP and NPRA may play an anti-cancer and carcinogenesis role, respectively, and this signaling pathway could be a more potent target for cancer therapy. In light of these new insights, this review will summarize the structures, functions, and their regulation by cell signaling, and their different impacts on tumors.

SCHLÜSSELWÖRTER: ANP, NPRA, cancer, target, treatment

Articles with similar content:

The c-Fes Family of Protein-Tyrosine Kinases
Critical Reviews™ in Oncogenesis, Vol.9, 1998, issue 1
Jim A. Rogers, Annemarie Shibata, Haiyun Cheng, Thomas E. Smithgall, Steven Schreiner, Kristi L. Peters, Jack M. Lionberger, Nancy Dunham, Jianze Li, Scott D. Briggs, Beata Scholtz
Enzymatic and Extraenzymatic Role of Adenosine Deaminase 1 in T-Cell-Dendritic Cell Contacts and in Alterations of the Immune Function
Critical Reviews™ in Immunology, Vol.27, 2007, issue 6
Rodrigo Pacheco, Rafael Franco, Carme Lluis, Teresa Gallart, Josep Maria Gatell
p120-CATENIN: A NOVEL REGULATOR OF INNATE IMMUNITY AND INFLAMMATION
Critical Reviews™ in Immunology, Vol.32, 2012, issue 2
Guochang Hu
Immunomodulatory and Cytoprotective Function of Atrial Natriuretic Peptide
Critical Reviews™ in Immunology, Vol.21, 2001, issue 6
Alexandra K. Kiemer, Angelika M. Vollmar
Hypotensive Activity of Mushroom Lectin of Tricholoma mongolicum S. Imai (Agaricomycetideae) in Comparison with Some Plant Lectins
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 4
Vincent Eng Choo Ooi, Hexiang Wang, Tzi Bun Ng